Cleared Traditional

K182327 - Patient Cables and Leadwires , Disposable ECG Leadwires (FDA 510(k) Clearance)

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K182327 · Orantech, Inc. · Cardiovascular device
Jan 2019
Decision
156d
Days
Class 2
Risk

K182327 is an FDA 510(k) clearance for the Patient Cables and Leadwires , Disposable ECG Leadwires. Classified as Cable, Transducer And Electrode, Patient, (including Connector) (product code DSA), Class II - Special Controls.

Submitted by Orantech, Inc. (Shenzhen, CN). The FDA issued a Cleared decision on January 30, 2019 after a review of 156 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2900 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

Submission Details

510(k) Number K182327 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 27, 2018
Decision Date January 30, 2019
Days to Decision 156 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Regulatory Context
Review time vs. panel average
16d slower than avg
Panel avg: 140d · This submission: 156d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DSA Cable, Transducer And Electrode, Patient, (including Connector)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2900
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DSA Cable, Transducer And Electrode, Patient, (including Connector)

Devices cleared under the same product code (DSA) and FDA review panel - the closest regulatory comparables to K182327.
Baylis Connector Cable
K254114 · Baylis Medical Technologies, Inc. · Jan 2026
IBP cable Becton Dickinson (2606488)
K252827 · Dr?gerwerk AG & Co KGaA · Dec 2025
IBP transducer adapter cable, Argon/BD/Ohmeda, 2m
K251669 · Shanghai Draeger Medical Instrument Co., Ltd. · Sep 2025
SpO2 Extension Cable
K242986 · Beijing Rongrui-Century Science & Technology Co., Ltd. · May 2025
RT Carbon ECG Leads
K240087 · Ivy Biomedical Systems, Inc. · Sep 2024
Medtronic Model 5492A, 5492V, 5492AL, 5492VL Patient Cables
K203556 · Medtronic, Inc. · Jul 2021